Multicenter, open-label study to evaluate the effects of methylphenidate-OROS (Concerta®) on cognitive functions in children with attention deficit hyperactivity disorder

Clinical Psychopharmacology and Neuroscience

Volumn 5, Issue 1, 2007, Pages 31-37

  Jung, Chulho ^a   Choi, Sangyong ^b   Jeong, Sunghoon ^c   Song, ChangJin ^d   Seo, Wanseok ^e   Chung, Un Sun ^c   Lee, Jonghun ^f  

^a Keimyung University   (South Korea)

^b Daegu Fatima Hospital   (South Korea)

^c Kyungpook National University Hospital   (South Korea)

^d Dongguk University College of Medicine   (South Korea)

^e Yeungnam University College of Medicine   (South Korea)

^f Catholic University of Daegu   (South Korea)

Author keywords

Attention deficit disorder with hyperactivity (ADHD); Cognitive function; KWISC III; Methylphenidate OROS

Indexed keywords

METHYLPHENIDATE;

ALERTNESS; ANOREXIA; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; INSOMNIA; INTELLECT; INTELLIGENCE QUOTIENT; KOREA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; SCHOOL CHILD; WORKING MEMORY;

EID: 33847794188     PISSN: 17381088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105:1158-1170.
2. Goldman-Rakic PS. Development of cortical circuitry and cognitive function. Child Dev 1987;58:601-622.
3. Shallice T. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 1982;298:199-209.
4. Arnsten AFT Castellanos FX. Neurobiology of attention regulation and its disorders. In: Martin A, Scahill L, Charney D and Leckman J., eds. Textbook of Child and Adolescent Psychopharmacology. NY: Oxford Univ. Press;2002. p.99-109.
5. Goldman-Rakic PS. The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philos Trans R Soc Lond B Biol Sci 1996;351:1445-1453.
6. Robbins TW. Dissociating executive functions of the prefrontal cortex. Philos Trans R Soc Lond B Biol Sci 1996;351:1463-1470;discussion 1470-1471.
7. Stuss DT, Knight RT. Principles of Frontal Lobe Function. New York: Oxford University Press; 2002. p.616.
8. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 1997;121:65-94.
9. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 2005;57:1336-1346.
10. Baddeley A. The fractionation of working memory. Proc Natl Acad Sci USA 1996;93:13468-13472.
11. Barkley RA, Grodzinsky G, DuPaul GJ. Frontal lobe functions in attention deficit disorder with and without hyperactivity: a review and research report. J Abnorm Child Psychol 1992;20:163-188.
12. Pennington BF, Ozonoff S. Executive functions and developmental psychopathology. J Child Psychol Psychiatry 1996;37:51-87.
13. Chelune GJ, Baer RA. Developmental norms for the Wisconsin Card Sorting Test. J Clin Exp Neuropsychol 1986;8:219-228.
14. Loge DV, Staton RD, Beatty WW. Performance of children with ADHD on tests sensitive to frontal lobe dysfunction. J Am Acad Child Adolesc Psychiatry 1990;29:540-545.
15. Grodzinsky GM, Diamond R. Frontal lobe functioning in boys with attention deficit hyperactivity disorder. Developmental Neuropsychology 1992;8:427-455.
16. Corkum PV, Siegel LS. Is the Continuous Performance Task a valuable research tool for use with children with Attention-Deficit-Hyperactivity Disorder? J Child Psychol Psychiatry 1993;34:1217-1239.
17. Shue KL, Douglas VI. Attention deficit hyperactivity disorder and the frontal lobe syndrome. Brain Cogn 1992;20:104-124.
18. Korkman M, Pesonen AE. A comparison of neuropsychological test profiles of children with attention deficit-hyperactivity disorder and/or learning disorder. J Learn Disabil 1994;27:383-392.
19. Todd RD, Botteron KN. Is attention-deficit/hyperactivity disorder an energy deficiency syndrome? Biol Psychiatry 2001;50:151-158.
20. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/ hyperactivity disorder. J Clin Psychopharmacol 2004;24:24-29.
21. Mehta MA, Goodyer IM, Sahakian BJ. Methylphenidate improves working memory and set-shifting in AD/HD: relationships to baseline memory capacity. J Child Psychol Psychiatry 2004;45:293-305.
22. Kempton S, Vance A, Maruff P, Luk E, Costin J, Pantelis C. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol Med 1999;29:527-538.
23. Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 1998;94:127-152.
24. Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, Fabiano GA, Morrisey SM, et al. Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 2001;107:E105.
25. Swanson J, Gupta S, Lam A, Shoulson I, Lerner M, Modi N, et al. Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies. Arch Gen Psychiatry 2003;60:204-211.
26. Gillberg C, Melander H, von Knorring AL, Janols LO, Thernlund G, Hagglof B, et al. Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997;54:857-864.
27. Gimpel GA, Collett BR, Veeder MA, Gifford JA, Sneddon P, Bushman B, et al. Effects of stimulant medication on cognitive performance of children with ADHD. Clin Pediatr (Phila) 2005;44:405-411.
28. Seo WS, Cheung SD, Lee JB, Kim JS, Youm HU, Bai DS, et al. The characteristics of executive dysfunction and changes after methylphenidate treatment in ADHD children. Korean J Psychopharmacol 2002;13:194-204.
29. Ha KS, Kwon JS, Lyoo IK, Kong SW, Lee DW, Youn T. Development and standardization process, and factor analysis of the computerized cognitive function test system for Korean adults. J Korean Neuropschiatr Assoc 2002;41:551-562.
30. Bai DS. Implementation of the Computerized Neuropsychological Test for the Children with ADHD. Department of Biomedical Engineering. Daegu: Yeungnam University;2003. p.176.
31. Wechsler D. Wechsler Intelligence Scale for Children. 3rd ed. San Antonio, TX: Psychological Corp;1991.
32. Kwak KJ, Park HW, Kim CT. Mannual of K-WISC-III. Seoul: Sepcial Education;2001.
33. Kaufman AS, Lichtenberger EO. Essentials of WISC-III and WPPSI-R Assessment. New York: Wiley;2000.
34. Gabrys JB. Methylphenidate effect on attentional and cognitive behavior in six- through twelve-year-old males. Percept Mot Skills 1977;45:1143-1149.
35. Kim HK. Comparison of executive and nonexecutive functions on the Wechsler intelligence test. The Korean J of Clinical Psychology 2006;25:257-271.
36. Brown RT, Borden KA, Wynne ME, Schleser R, Clingerman SR. Methylphenidate and cognitive therapy with ADD children: a methodological reconsideration. J Abnorm Child Psychol 1986;14:481-497.
37. Losier BJ, McGrath PJ, Klein RM. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psychiatry 1996;37:971-987.
38. Solanto MV, Wender EH, Bartell SS. Effects of methylphenidate and behavioral contingencies on sustained attention in attention-deficit hyperactivity disorder: a test of the reward dysfunction hypothesis. J Child Adolesc Psychopharmacol 1997;7:123-136.
39. Musten LM, Firestone P, Pisterman S, Bennett S, Mercer J. Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions. J Am Acad Child Adolesc Psychiatry 1997;36:1407-1415.
40. Aman MG, Marks RE, Turbott SH, Wilsher CP, Merry SN. Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance. J Am Acad Child Adolesc Psychiatry 1991;30:816-824.
41. Klorman R, Brumaghim JT, Fitzparrick PA, Borgstedt AD. Methylphenidate speeds evaluation processes of attention deficit disorder adolescents during a continuous performance test. J Abnorm Child Psychol 1991;19:263-283.
42. Conners CK, Taylor E. Pemoline, methylphenidate, and placebo in children with minimal brain dysfunction. Arch Gen Psychiatry 1980;37:922-930.
43. Lee HA, Park HB, Bai DS, Baik YM. The effect of attention level of attention deficit hyperactivity disorder on CPT and WCST. J Korean Neuropschiatr Assoc 2001;40:656-666.
44. Toplak ME, Jain U, Tannock R. Executive and motivational processes in adolescents with Attention-Deficit-Hyperactivity Disorder (ADHD). Behav Brain Funct 2005;1:8.
45. Lawrence V, Houghton S, Douglas G, Durkin K, Whiting K, Tannock R. Executive function and ADHD: a comparison of children's performance during neuropsychological testing and real-world activities. J Atten Disord 2004;7:137-149.
46. Martinussen R, Hayden J, Hogg-Johnson S, Tannock R. A meta-analysis of working memory impairments in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2005;44:377-384.
47. O'Driscoll GA, Depatie L, Holahan AL, Savion-Lemieux T, Barr RG, Jolicoeur C, et al. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005;57:1452-1460.
48. Romine CB, Lee D, Wolfe ME, Homack S, George C, Riccio CA. Wisconsin Card Sorting Test with children: a meta-analytic study of sensitivity and specificity. Arch Clin Neuropsychol 2004;19:1027-1041.
49. Yang P, Chung LC, Chen CS, Chen CC. Rapid Improvement in academic grades following methylphenidate treatment in attention-deficit hyperactivity disorder. Psychiatry Clin Neurosci 2004;58:37-41.
50. Tannock R, Schachar R. Methylphenidate and cognitive perseveration in hyperactive children. J Child Psychol Psychiatry 1992;33:1217-1228.
51. Lowe C, Rabbitt P. Test/re-test reliability of the CANTAB and ISPOCD neuropsychological batteries: theoretical and practical issues. Cambridge Neuropsychological Test Automated Battery. International Study of Post-Operative Cognitive Dysfunction. Neuropsychologia 1998;36:915-923.
52. Ernst M. PET in child psychiatry: the risks and benefits of studying normal healthy children. Prog Neuropsychopharmacol Biol Psychiatry 1999;23:561-570.